GE Aerospace (GE) is set to announce Q4 earnings, with analysts focused on engine deliveries, margins, and aftermarket growth ...

In a report released yesterday, Michael Dahl from RBC Capital maintained a Sell rating on DR Horton (DHI – Research Report), with a price ...

J.P. Morgan analyst Anthony Paolone maintained a Buy rating on W. P. Carey Inc. (WPC – Research Report) on January 16 and set a price target of ...

NFJ Investment Group CIO John Mowrey reacts to real estate giant Brookfield defaulting on $161 million mortgage for office properties on 'The Claman Countdown.' Carnivore Trading CEO Dutch Masters and ...

The move is the latest recruiting win for RBC Wealth Management as it continues to lure top talent away from big banks and ...

SmartCentres Real Estate Investment Trust ("SmartCentres" or the "Trust") announced today that it has priced an offering of $300 million aggregate principal amount of 4.737% Series AB senior unsecured ...

While Biogen has made an opportunistic bid for partner Sage, its top executive seemed to play down the urgency for his ...

Partners from Latham, Proskauer, Kirkland, Morrison Foerster and Skadden say they are optimistic about 2025, citing activity ...

J.P. Morgan analysts said the CMS’ review “validates the technology and could potentially move the needle on growth for Medtronic.” ...

Johnson & Johnson kicked off the J.P. Morgan Healthcare Conference on Monday with the $14.6 billion acquisition of Intra-Cellular Therapies.

"Fixed income is beginning 2025 where it left off 2024, which is to say yields are moving higher," said Daryl Clements, a municipal portfolio manager at AllianceBernstein.